Consensus Alvotech

Equities

ALVO

LU2458332611

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
12.12 ^USD	-0.25%		-0.33%	+5.57%

Jul. 02	Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints	MT
Jul. 02	Alvotech Announces Positive Topline Results from Confirmatory Patient Study for Avt03, A Proposed Biosimilar for Prolia® and Xgeva®	CI

Evolution of the average Target Price on Alvotech

Price target over the last 5 years

History of analyst recommendation changes

e7f47e593c23951b768328c7a5343a7.Hvn_CxvFo4jIoKAPdLoNK-AwqmSt4bFobB8v2Io93dY.bpyubFOS5te-leF4Fsp_aKZW0D6cqPA9O2lW6v1v64V1rK9fav3Sx_rU9Q~a33bf67da57d0ada53a3228f91aa68e8

Analyst Recommendations on Alvotech

Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating	May. 24	MT
Barclays Raises Price Target on Alvotech to $20 From $17, Maintains Overweight Rating	Mar. 22	MT
Barclays Upgrades Alvotech to Overweight From Equalweight, Raises Price Target to $17 From $10	Jan. 29	MT
Citigroup Upgrades Alvotech to Neutral From Sell, Adjusts Price Target to $10 From $5	23-10-20	MT
Barclays Initiates Alvotech With Equalweight Rating, Price Target is $10	23-09-21	MT
Deutsche Bank Adjusts Alvotech Price Target to $8 From $12, Maintains Hold Rating	23-06-30	MT
Deutsche Bank Adjusts Alvotech's Price Target to $12 From $8, Maintains Hold Rating	23-03-07	MT
Morgan Stanley Starts Alvotech at Equalweight With $10 Price Target	22-09-07	MT
Citigroup Double Downgrades Alvotech to Sell From Buy, Adjusts Price Target to $5 From $12	22-09-06	MT
Citigroup Starts Alvotech at Buy With $12 Price Target	22-07-26	MT
Deutsche Bank Initiates Coverage on Alvotech With Hold Rating, $10 Price Target	22-07-01	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

OUTPERFORM

Number of Analysts

6

Last Close Price

12.12 USD

Average target price

17.5 USD

Spread / Average Target

+44.39%

High Price Target

28 USD

Spread / Highest target

+131.02%

Low Price Target

6 USD

Spread / Lowest Target

-50.50%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alvotech

Barclays
Citigroup
Deutsche Bank Securities
Morgan Stanley

Ratings for Alvotech

Trading Rating

Investor Rating

ESG Refinitiv

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Stock Market
Equities
ALVO Stock
Consensus Alvotech

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer